World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
13695
World Ranking
2626
National Ranking
1251

Overview

Anna P. Durbin is affiliated with Johns Hopkins University in the United States and primarily publishes research in the field of Medicine. Their work focuses extensively on Public Health, Environmental and Occupational Health, Infectious Diseases, and Epidemiology, with additional contributions in Health and Modeling and Simulation.

The scientist's research thèmes concentrate on mosquito-borne diseases and control, viral infections and vectors, malaria research and control, viral infections and outbreaks research, virology and viral diseases, SARS-CoV-2 and COVID-19 research, as well as vaccine coverage and hesitancy.

Frequent coauthors in their publications include:

  • Stephen S. Whitehead
  • Sean A. Diehl
  • Beth D. Kirkpatrick
  • Kristen K. Pierce
  • Usha K. Nivarthi

Their research has appeared in a range of publication venues, notably:

  • UNC Libraries
  • The Lancet Infectious Diseases
  • Nature Communications
  • Biologicals
  • Journal of Virology

Recent published papers include:

  • US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 (2021, JAMA)
  • Dengue: A Growing Problem With New Interventions (2022, PEDIATRICS)
  • Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial (2020, The Lancet Infectious Diseases)
  • T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species (2020, Journal of Virology)
  • A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans (2021, Nature Communications)

Best Publications

  • Prospects for a dengue virus vaccine.

    Stephen S. Whitehead;Joseph E. Blaney;Anna P. Durbin;Brian R. Murphy

  • Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

    Yimin Wu;Ruth D. Ellis;Donna Shaffer;Erica Fontes

  • US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

    Isaac See;John R. Su;Allison Lale;Emily Jane Woo

  • Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

    Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn

  • Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

    Ann R Falsey;Magdalena E Sobieszczyk;Ian Hirsch;Stephanie Sproule

  • Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria

    Elissa M. Malkin;David J. Diemert;Julie H. McArthur;John R. Perreault

  • Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

    Anna P. Durbin;Maria José Vargas;Kimberli Wanionek;Samantha N. Hammond

  • Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

    Elissa M. Malkin;Anna P. Durbin;David J. Diemert;Jetsumon Sattabongkot

  • The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

    Beth D. Kirkpatrick;Stephen S. Whitehead;Kristen K. Pierce;Cecilia M. Tibery

  • Dengue viruses cluster antigenically but not as discrete serotypes

    Leah C. Katzelnick;Judith M. Fonville;Judith M. Fonville;Judith M. Fonville;Gregory D. Gromowski;Jose Bustos Arriaga

  • Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

    Beth D. Kirkpatrick;Anna P. Durbin;Kristen K. Pierce;Marya P. Carmolli

  • Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

    Steevenson Nelson;Christiane A. Jost;Qinq Xu;Jessica Ess

  • Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.

    Alba Grifoni;John Pham;John Sidney;Patrick H O'Rourke

  • A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.

    Kimberly A. Dowd;Christiane A. Jost;Anna P. Durbin;Stephen S. Whitehead

  • A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

    Anna P. Durbin;Beth D. Kirkpatrick;Kristen K. Pierce;Daniel Elwood

  • The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes

    Daniela Weiskopf;Michael A. Angelo;Derek J. Bangs;John Sidney

  • rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers

    Anna P. Durbin;Stephen S. Whitehead;Julie McArthur;John R. Perreault

  • The dengue vaccine pipeline: Implications for the future of dengue control

    Lauren M. Schwartz;M. Elizabeth Halloran;Anna P. Durbin;Ira M. Longini

  • Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response

    Carleigh B Krubiner;Ruth R Faden;Ruth A Karron;Margaret O Little

  • Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.

    Kawsar R. Talaat;Ruth D. Ellis;Janet Hurd;Autumn Hentrich

  • Mutations in the C, D, and V Open Reading Frames of Human Parainfluenza Virus Type 3 Attenuate Replication in Rodents and Primates

    Anna P. Durbin;Josephine M. McAuliffe;Peter L. Collins;Brian R. Murphy

Frequent Co-Authors

Stephen S. Whitehead
Stephen S. Whitehead National Institute of Allergy and Infectious Diseases
Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Aravinda M. de Silva
Aravinda M. de Silva University of North Carolina at Chapel Hill
Daniela Weiskopf
Daniela Weiskopf La Jolla Institute For Allergy & Immunology
Eva Harris
Eva Harris University of California, Berkeley
Brian R. Murphy
Brian R. Murphy National Institute of Allergy and Infectious Diseases
Louis H. Miller
Louis H. Miller National Institute of Allergy and Infectious Diseases
Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Alba Grifoni
Alba Grifoni La Jolla Institute For Allergy & Immunology
Angel Balmaseda
Angel Balmaseda University of California, Berkeley

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can open up diverse career pathways. Many students consider transitioning into nursing roles, which complement immunological expertise with patient care skills. For example, nurses can advance their practice by pursuing an acute care certification for FNP, allowing them to specialize in critical and complex patient care.

Accelerated degree options make it easier to quickly meet career goals. Programs like accelerated FNP programs provide a fast-tracked route to becoming a Family Nurse Practitioner, blending clinical experience with expanded responsibilities. Similarly, those without a nursing background can enter the field through some of the best online BSN programs for non nurses, which offer foundational nursing education accessible from anywhere.

For quicker entry into nursing, the 12-month accelerated nursing programs stand out for their condensed curriculum and efficient format. These programs are ideal for individuals seeking to transition into nursing within a year while maintaining high educational standards.

By leveraging these online degree options, students and professionals in immunology can broaden their expertise and expand their impact in healthcare settings. Each pathway offers unique benefits, catering to different career goals and timelines.

Learn more about acute care certification for fnp, explore top accelerated fnp programs, discover the best online bsn programs for non nurses, and consider fast-tracking your career with 12-month accelerated nursing programs.

Best Scientists Citing Anna P. Durbin

Trending Scientists

Recently Published Articles